Physician profile
Robert Boone
NPI 1164440020
$970.88
in general payments reported to CMS, 2019-2025
24 companies · $20.37 in 2025
The $20.37 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $201 · 2021: $131 · 2022: $215 · 2023: $32.68 · 2024: $15.16 · 2025: $20.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $68.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $68.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $171.02 | 2019-2021 | |
| Therapeuticsmd, INC. | $116.12 | 2019-2022 | |
| Edwards Lifesciences Corporation | $98.73 | 2022 | |
| Exeltis, USA INC. | $81.99 | 2020-2024 | Slynd |
| Amag Pharmaceuticals, INC. | $68.96 | 2019-2020 | |
| Myovant Sciences INC. | $61.21 | 2021-2022 | |
| Daiichi Sankyo INC. | $46.85 | 2019-2020 | |
| Novo Nordisk INC | $40.82 | 2019-2025 | Wegovy |
| Covidien Lp | $33.26 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.58 | 2020 | |
| Vertical Pharmaceuticals, LLC | $26.05 | 2019 | |
| Heron Therapeutics, INC. | $22.73 | 2022 | |
| Millicent US INC | $22.48 | 2019-2020 | |
| Boston Scientific Corporation | $19.08 | 2019 | |
| Sumitomo Pharma America, INC. | $17.19 | 2023 | Myfembree |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $16.51 | 2022 | |
| Coopersurgical, INC. | $15.79 | 2022 | |
| Mayne Pharma Commercial LLC | $15.49 | 2021 | |
| Merck Sharp & Dohme LLC | $12.55 | 2019 | |
| Ethicon US, LLC | $12.20 | 2021 | |
| Minerva Surgical, INC | $11.80 | 2019 | |
| Pfizer INC. | $11.32 | 2019 | |
| Avion Pharmaceuticals | $11.29 | 2019 | |
| Mallinckrodt Enterprises LLC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Boone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.